Identifying risk factors for aggressive melanoma in veterans
Official title: Risk Factors for Clinically Aggressive Melanoma in Veterans
Funded at VA Boston Health Care System · NIH-10975905 · Data updated 2026-11-12
This study is looking at what makes melanoma more aggressive in veterans over 65, and it aims to create a helpful tool to spot the disease earlier and improve treatment, so veterans can get better care tailored to their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Boston Health Care System NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | October 1, 2023 |
| Project end | September 30, 2028 |
| Funding year | 2025 |
| NIH project number | 5IK2CX002531-02 |
| Project ID | NIH-10975905 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans aged 65 and older who may be at risk for developing clinically aggressive melanoma.
✕Less likely to help
Patients who are younger than 65 or those without a history of melanoma or significant risk factors may not benefit from this research.
What this research studies
This research investigates the risk factors associated with clinically aggressive melanoma in veterans, particularly those aged 65 and older. The study aims to develop and validate a clinical risk prediction model that incorporates both genetic and phenotypic factors to improve early detection and treatment outcomes. By analyzing various demographics, co-morbidities, and environmental exposures, the research seeks to create personalized screening approaches that can be easily implemented in clinical settings. The ultimate goal is to enhance melanoma screening and reduce the burden of this disease among veterans.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and treatment of aggressive melanoma, potentially saving lives and reducing healthcare costs.
How similar studies have gone: Previous research has shown promise in developing risk prediction models for melanoma, indicating that this approach could be effective.
Where this research is happening
-
VA Boston Health Care System
Boston, United States Active
Researchers
- Principal investigator: Hartman, Rebecca Ivy — VA Boston Health Care System
- Study coordinator: Hartman, Rebecca Ivy
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetic, behavior, and vascular data
Aims to predict Alzheimer’s disease risk in middle-aged South Asians by combining genetic, lifestyle, and vascular information to catch early changes before dementia develops.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetics, behavior, and vascular data
Aimed at people 21 and older, this project looks at how biology, behavior, and blood vessel health together may signal the early risk of Alzheimer’s disease and related dementias in South Asians.
-
Melanoma vaccine built from tiny spherical nucleic acids
A new kind of cancer vaccine using tiny spherical nucleic acids to help the immune system fight advanced melanoma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.